Cancer Chemoresistance; Recent Challenges and Future Considerations
Author:
Publisher
Springer International Publishing
Link
https://link.springer.com/content/pdf/10.1007/978-3-031-27156-4_12
Reference101 articles.
1. Alfarouk KO, Stock C-M, Taylor S, Walsh M, Muddathir AK, Verduzco D, Bashir AH, Mohammed OY, Elhassan GO, Harguindey S (2015) Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp. Cancer Cell Int 15(1):1–13
2. Andreotti PE, Linder D, Hartmann DM, Cree IA, Pazzagli M, Bruckner HW (1994) TCA-100 tumour chemosensitivity assay: differences in sensitivity between cultured tumour cell lines and clinical studies. J Biolumin Chemilumin 9(6):373–378
3. Ankathil R (2019) The mechanisms and challenges of cancer chemotherapy resistance: a current overview. Eur J Mol Clin Med 6(1):26–34
4. Aoudjit F, Vuori K (2012) Integrin signaling in cancer cell survival and chemoresistance. Chemother Res Pract 2012
5. Azzarito T, Venturi G, Cesolini A, Fais S (2015) Lansoprazole induces sensitivity to suboptimal doses of paclitaxel in human melanoma. Cancer Lett 356(2):697–703
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Synergistic Mechanisms of Selected Polyphenols in Overcoming Chemoresistance and Enhancing Chemosensitivity in Colorectal Cancer;Antioxidants;2024-07-07
2. The novel SMYD3 inhibitor EM127 impairs DNA repair response to chemotherapy-induced DNA damage and reverses cancer chemoresistance;Journal of Experimental & Clinical Cancer Research;2024-05-30
3. The accumulation of sphingosine kinase 2 disrupts the DNA damage response and promotes resistance to genotoxic agents;Gene;2024-03
4. Tephrosin Suppresses the Chemoresistance of Paclitaxel-Resistant Ovarian Cancer via Inhibition of FGFR1 Signaling Pathway;Biomedicines;2023-11-27
5. Role of exosomes in transferring chemoresistance through modulation of cancer glycolytic cell metabolism;Cytokine & Growth Factor Reviews;2023-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3